Chris McGee, MSc, is a senior scientist in the diagnostic products R&D group at PerkinElmer’s Horizon Discovery. Chris has contributed to the development of a range of RNA- and DNA-based genetic reference standards focused primarily on oncology next-generation sequencing (NGS).
Recently, Chris led the development of Horizon’s latest Pan-Cancer 6-Fusion RNA control. Prior to joining Horizon, Chris worked at the Wellcome Trust Sanger Institute in Cambridge (UK) and the University of Galway.
Articles by Christopher McGee, MSc
|2 min read
The Power of RNA in Detecting Gene Fusions for Cancer Diagnostics
RNA profiling provides an effective and accurate method of gene fusion detection for clinical oncology diagnosticsPage 1 of 1
